SuperX
  1. Home
  2. Stocks
  3. GSKCH

No trade has been recorded for GSKCH since 30 Jan 2023 — 1,390 days before 20 Nov 2026. The figures on this page are from that session.

GSKCH GlaxoSmithKline Consumer Healthcare share price

GlaxoSmithKline Consumer Healthcare in one paragraph

GlaxoSmithKline Consumer Healthcare (GSKCH) last traded at Rs 120.23 on 30 Jan 2023. Its market capitalisation is about Rs 14.1B. GlaxoSmithKline Consumer Healthcare is in the Pharmaceuticals sector.

Close · 30 Jan 2023 · Pakistan Stock Exchange · Vol 8.5K

Rs 120.23

−3.88 (−3.13%)

Chart GSKCH in SuperX Apex

On 31 Jan 2023 this ticker became HALEON, Haleon Pakistan Limited. The price history continues on the HALEON page. Open HALEON

GSKCH · 1-year close

No price history available for this symbol yet.

1 week
−4.71%
1 month
−26.64%
3 months
−39.91%
6 months
−44.83%
Year to date
−26.64%
1 year
−54.75%
3 years
−50.61%
5 years
−71.34%
Last price
Rs 120.23
30 Jan 2023
Change on the day
−3.13%
−Rs 3.88
Market cap

Market cap

What the whole company costs at today's price.

How it's worked out

Share price multiplied by every share in issue.

How to read it

It is the company's size, not its value. A big number does not mean the price is high against earnings, and a small one does not mean it is low — that is what the ratios below are for.

Rs 14.1B
as of 20 Nov 2026
Price per rupee earned

Price per rupee earned

Rupees you pay for each rupee the company earned last year.

How it's worked out

Share price divided by earnings per share over the last twelve reported months.

How to read it

Lower only means something against something — the same company's history, its sector, or the market. On its own this ratio says very little, and it is blank when a company lost money.

—
Dividend yield

Dividend yield

Cash paid out over the last year as a percentage of today's price.

How it's worked out

Dividends per share over twelve months divided by the share price.

How to read it

A very high yield is often a warning, not a gift: it usually means the price fell. Check the payout ratio next to see whether earnings actually cover it.

—
Earnings per share
Rs 18.23
the year to 31 Dec 2021
52-week range
—
Day range
—
prev close 124.11
Volume
8.5K
shares, this session
Avg volume (30d)

Average volume

Shares changing hands on a typical day.

How it's worked out

The mean daily volume over thirty sessions.

How to read it

Shares, not rupees — a million shares of a Rs 3 stock is a small market. "Traded per session" is the version in money.

13.6K
5 more figures
Shares outstanding

Shares outstanding

Every share the company has issued.

How it's worked out

The share count in the company's own filings, including the blocks nobody trades.

How to read it

Divide any per-share figure by this. It is larger than the free float on almost every PSX name, because sponsors and the government own shares that never reach the market.

117M
Free float

Free float

The shares that can actually be bought and sold.

How it's worked out

Total shares minus the blocks held by sponsors, the government and other locked-in holders, as the exchange reports them.

How to read it

The float, not the market cap, is what sets how easily a real position can be built or unwound.

15.6M
13.3% of shares
Last results filed
21 Oct 2022
Shariah
—

Figures as of 30 Jan 2023.

There is no SuperX note for GlaxoSmithKline Consumer Healthcare yet. A note is written after a market close.

01Returns1 year −54.75%
02ValueAgainst the sector

The same ratio on other definitions

GSKCH earnings per share: Rs 18.23 · unconsolidated · the year to 31 Dec 2021 · PSX company page

Price per rupee earned, our own: 6.60 (120.23 on 30 Jan 2023 over 18.23, unconsolidated, the year to 31 Dec 2021)

Brokers’ price targets

Brokers’ 12-month price targets for GSKCH, not SuperX’s

Collected from sell-side research notes. The figures here are the brokers’.

No broker covers GSKCH in our records. Brokers cover 49 PSX companies and rate 47 of them buy.

03Grades and checksGrades A to F
04ResultsBy year and by quarter
Sales, profit and earnings per share, by year

What are GSKCH’s sales, profit and earnings per share?

Annual figures from the accounts filed with PSX. Amounts in rupees; earnings per share (EPS) in rupees a share.

Statements in SuperX Apex

FY (December) 2021202020192018
Sales Rs 24.2BRs 19.8BRs 16.3BRs 14.9B
Profit after Taxation Rs 2.1BRs 1.3BRs 1.3BRs 1.1B
EPS Rs 18.23Rs 10.78Rs 10.74Rs 9.18
EPS Growth +69.1%+0.4%+17.0%+24.2%
Gross Profit Margin 27.4%26.9%30.6%29.2%
Net Profit Margin 8.8%6.4%7.7%7.2%
05AccountsCash, debt and the balance sheet
06DividendsEvery payout
Every payout

GSKCH dividends and corporate actions

PSX quotes payouts as a % of the Rs 10 face value — 25% = Rs 2.50 per share. Unconfirmed ex-dates are marked “expected”.

Payouts in SuperX Apex

GSKCH dividends and corporate actions
Type % of face Per share Ex-date Book closure Qualify by
No dividends or corporate actions on record for GSKCH.
07Peers6 companies
Peers table

Other Pharmaceuticals stocks on PSX

Other companies in the same PSX sector, including its largest.

GSKCH sector peers
Symbol Company Price Chg % Mkt cap Price/earnings
HALEON Haleon Pakistan Limited 687.73 0.00% Rs 80.5B 12.3×
HINOON Highnoon Laboratories Limited 976.84 +1.74% Rs 51.8B 12.6×
HPL Hoechst Pakistan Limited 4,000.00 0.00% Rs 38.6B 11.0×
GLAXO GlaxoSmithKline Pakistan Limited 332.02 −0.92% Rs 106B 9.6×
ABOT Abbott Laboratories (Pakistan) Limited 1,013.28 +0.42% Rs 99.2B 10.7×
SEARL The Searle Company Limited 79.69 +0.18% Rs 46.9B 12.1×

6 of 6 companies shown have a price-to-earnings ratio in Pharmaceuticals; a blank cell means a loss or no ratio. Each ratio is the one printed on that company’s own page.

All Pharmaceuticals stocks on PSX

08Price position52-week range and readings
09OwnersWho owns the shares
About the company

About GlaxoSmithKline Consumer Healthcare

GlaxoSmithKline Consumer Healthcare Pakistan Limited was incorporated in Pakistan as a public unlisted company under the provisions of the repealed Companies Ordinance, 1984 (now Companies Act, 2017) on March 31, 2015 principally to effect the demerger of consumer healthcare business of GlaxoSmithKline Pakistan Limited (GSK Pakistan). The Company is a subsidiary of GlaxoSmithKline Consumer Healthcare B.V. The ultimate parent of the Company is Haleon plc. The Company is engaged in manufacturing, marketing and sale of consumer healthcare products.

Head office
Sandoz Nagar, Petaro Road, Jamshoro, Sindh.
Auditor
Yousuf Adil, Chartered Accountants
Share registrar
CDC Share Registrar Services Limited CDC House, Main Shahrah-e-Faisal, Karachi.
Fiscal year end
December
10Dated record22 dated events
The dated record

GSKCH’s dated record

The exchange’s own record and ours: ex-dividends, book closures, results, every session move of 3% or more with the reason written out, the notices that move a price, and the news about GlaxoSmithKline Consumer Healthcare. Dates that have not happened are kept apart from dates that have, and each one says whether it was announced or projected.

Earlier · 22

Notice 20 notices, 1 Mar 2021 to 5 Dec 2022 open
  • 5 Dec 2022 Board meeting Results of the Board of Directors Meeting Other than Financial Results
  • 25 Nov 2022 Board meeting Notice of Board Meeting Other Than Financial Results
  • 21 Oct 2022 Financial results Financial Results for the Quarter Ended 30 September 2022
  • 13 Oct 2022 Board meeting Notice of Board of Directors Meeting - (Q3-2022)
  • 23 Aug 2022 Financial results Financial Results for the Quarter Ended 30 June 2022
  • 15 Aug 2022 Board meeting Notice of Board of Directors Meeting - (Q2-2022)
  • 25 Apr 2022 Financial results Financial Results for the Quarter Ended 31 March 2022
  • 22 Apr 2022 Board meeting Board Meeting in Progress
  • 14 Apr 2022 Board meeting Notice of Board of Directors Meeting - (Q1-2022)
  • 9 Feb 2022 Financial results Financial Results for the Year Ended 31 December 2021
  • 3 Feb 2022 Board meeting Board of Directors Meeting - (Q4-2021)
  • 2 Feb 2022 Board meeting 23rd Board of Directors Meeting REVOKED
  • 26 Oct 2021 Financial results Financial Results for the Quarter Ended 30 September 2021
  • 15 Oct 2021 Board meeting Notice of Board Meeting (Q3-2021)
  • 24 Aug 2021 Financial results Financial Result for the Quarter Ended 2021-06-30
  • 13 Aug 2021 Board meeting Notice of Board Meeting (Q2-2021)
  • 23 Apr 2021 Financial results Financial Results for the Quarter Ended 2021-03-31
  • 16 Apr 2021 Board meeting Notice of Board Meeting (Q1-2021)
  • 5 Mar 2021 Financial results Financial Results for the Year Ended December 31, 2020
  • 1 Mar 2021 Board meeting Board Meeting - Q4-2020
Results 2 results filings, 21 Oct 2022 to 15 Aug 2026 open
  • 15 Aug 2026 Half-year results expected between 15 Aug 2026 and 2 Sep 2026 projected A window from past filings, not a date the company gave.
  • 21 Oct 2022 Nine-month results, to 30 Sep 2022

Showing the most recent notices. Every ex-dividend, book closure, results filing and ticker change is listed.

Dates and events on this page are read as of 20 Nov 2026.

11QuestionsQuick answers

GSKCH share price: quick answers

What is the GlaxoSmithKline Consumer Healthcare (GSKCH) share price?

GlaxoSmithKline Consumer Healthcare (GSKCH) last traded at Rs 120.23 on 30 Jan 2023.

What is GSKCH's dividend yield?

No trailing dividend yield is shown for GlaxoSmithKline Consumer Healthcare (GSKCH) as of 30 Jan 2023. Check the dividend history table on this page for declared payouts.

How much does GSKCH cost for each rupee it earns?

SuperX cannot price GSKCH against its earnings as of 30 Jan 2023, because the trailing twelve months show no profit to divide by — the earnings are negative or not yet reported. See the financials table for reported earnings per share.

Is GSKCH Shariah compliant?

No Shariah screening status is shown for GSKCH as of 30 Jan 2023.

What happened to GSKCH?

On 31 Jan 2023 this ticker became HALEON, Haleon Pakistan Limited. The price history continues on the HALEON page.

Where is the head office of GlaxoSmithKline Consumer Healthcare?

The head office of GlaxoSmithKline Consumer Healthcare (GSKCH) is at Sandoz Nagar, Petaro Road, Jamshoro, Sindh (PSX company page, 3 Nov 2026).

Who is the auditor of GlaxoSmithKline Consumer Healthcare?

The auditor of GlaxoSmithKline Consumer Healthcare (GSKCH) is Yousuf Adil, Chartered Accountants (PSX company page, 3 Nov 2026).

Who is the share registrar of GlaxoSmithKline Consumer Healthcare?

The share registrar of GlaxoSmithKline Consumer Healthcare (GSKCH) is CDC Share Registrar Services Limited CDC House, Main Shahrah-e-Faisal, Karachi (PSX company page, 3 Nov 2026).

When does the financial year of GlaxoSmithKline Consumer Healthcare end?

The financial year of GlaxoSmithKline Consumer Healthcare (GSKCH) ends in December (PSX company page, 3 Nov 2026).

How many shares of GlaxoSmithKline Consumer Healthcare are outstanding?

GlaxoSmithKline Consumer Healthcare (GSKCH) has 117,054,508 shares outstanding (PSX company page, 3 Nov 2026).

What is the free float of GlaxoSmithKline Consumer Healthcare?

The free float of GlaxoSmithKline Consumer Healthcare (GSKCH) is 13.3% of its shares (PSX company page, 3 Nov 2026).

What does GlaxoSmithKline Consumer Healthcare do?

The company profile on PSX (3 Nov 2026) reads: GlaxoSmithKline Consumer Healthcare Pakistan Limited was incorporated in Pakistan as a public unlisted company under the provisions of the repealed Companies Ordinance, 1984 (now Companies Act, 2017) on March 31, 2015 principally to effect the demerger of consumer healthcare business of GlaxoSmithKline Pakistan Limited (GSK Pakistan). The Company is a subsidiary of GlaxoSmithKline Consumer Healthcare B.V.

Answers use the facts on this page. Prices are as of 30 Jan 2023.

12SourcesGuides, filings and sources

Guides for GSKCH

Plain explanations of the figures on this page.

Filings and reports

GlaxoSmithKline Consumer Healthcare filings and reports

20 documents GlaxoSmithKline Consumer Healthcare has published — annual reports, quarterly accounts and briefing decks. PSX filings are marked PSX; the rest come from the company’s own investor relations page. Links open the original PDF at the source.

Filings in SuperX Apex

Data from PSX via SuperX, delayed and provided for information only — not investment advice. Figures may contain errors; verify with your broker before acting. As of .

Track GSKCH in your portfolio, from 23 December

Trade logging, price alerts and smart-money flows for PSX investors. Join the waitlist and we email once, when it is ready.

SuperX is not a broker and not an adviser. It never places an order and never asks for a broker login.

Get early access, free